These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39241319)

  • 1. Preferences of US adolescents and parents for vaccination against invasive meningococcal disease.
    Schley K; Whichello C; Hauber B; Krucien N; Cappelleri JC; Peyrani P; Presa JV; Coulter J; Heidenreich S
    Vaccine; 2024 Nov; 42(25):126264. PubMed ID: 39241319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Qualitative Research to Quantitative Preference Elicitation: An Example in Invasive Meningococcal Disease.
    Coulter J; Whichello C; Heidenreich S; Hauber B; Michaels-Igbokwe C; Cappelleri JC; Peyrani P; Vespa Presa J; Venkatraman M; Schley K
    Patient; 2024 May; 17(3):319-333. PubMed ID: 38388957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
    Marshall HS; Chen G; Clarke M; Ratcliffe J
    Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying Stated Preferences for Meningococcal Vaccines Among Adolescents/Young Adults and Parents of Adolescents in the United States: A Discrete Choice Experiment.
    Begum S; Cabrera ES; Restrepo OH; Burman C; Sohn WY; Kuylen E; Shah H; Kocaata Z
    Infect Dis Ther; 2024 Sep; 13(9):2001-2015. PubMed ID: 39044053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment.
    Salisbury D; Lazarus JV; Waite N; Lehmann C; Sri Bhashyam S; de la Cruz M; Hahn B; Rousculp MD; Bonanni P
    JMIR Public Health Surveill; 2024 Oct; 10():e57242. PubMed ID: 39412841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.
    Srivastava A; Dempsey A; Galitsky A; Fahimi M; Huang L
    BMC Public Health; 2020 Jul; 20(1):1109. PubMed ID: 32664872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial.
    Peterson J; Drazan D; Czajka H; Maguire J; Pregaldien JL; Seppa I; Maansson R; O'Neill R; Balmer P; Jodar L; Jansen KU; Anderson AS; Perez JL; Beeslaar J
    Lancet Infect Dis; 2023 Dec; 23(12):1370-1382. PubMed ID: 37579773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults.
    Herrera-Restrepo O; Zhou Z; Krishnan A; Conley WJ; Oladele E; Multani JK; Tuly R; Shi L; Chen CC; Preiss S; Clements DE
    Curr Med Res Opin; 2024 Jan; 40(1):125-140. PubMed ID: 38032143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential public health impact of a
    Huang L; Snedecor SJ; Balmer P; Srivastava A
    Postgrad Med; 2022 May; 134(4):341-348. PubMed ID: 33615973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial.
    Block SL; Szenborn L; Daly W; Jackowska T; D'Agostino D; Han L; Dull PM; Smolenov I
    Vaccine; 2015 May; 33(21):2500-10. PubMed ID: 25795256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of regional disparities on the availability of meningococcal vaccines in the US.
    Schley K; Jodar E; Presa JV; Willis SJ; Prener CG
    BMC Public Health; 2024 Jul; 24(1):1771. PubMed ID: 38961431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal disease and vaccination: Knowledge and acceptability among adolescents in Italy.
    Pelullo CP; Napolitano F; Di Giuseppe G
    Hum Vaccin Immunother; 2018 May; 14(5):1197-1202. PubMed ID: 29452028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp.
    Burman C; Alderfer J; Snow VT
    J Clin Pharm Ther; 2020 Apr; 45(2):270-281. PubMed ID: 31820483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines: A Phase 2 Randomized Study.
    Szenborn L; Block SL; Jackowska T; Konior R; D'Agostino D; Smolenov I; Toneatto D; Welsch JA
    Pediatr Infect Dis J; 2018 May; 37(5):475-482. PubMed ID: 29329168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens.
    Basta NE; Becker AB; Li Q; Nederhoff D
    Vaccine; 2019 Jan; 37(4):670-676. PubMed ID: 30587431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
    Welsch JA; Senders S; Essink B; Klein T; Smolenov I; Pedotti P; Barbi S; Verma B; Toneatto D
    Vaccine; 2018 Aug; 36(35):5309-5317. PubMed ID: 30061029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Communication on HPV Vaccination to Parents of 11- to 14-Year-Old Adolescents in France: A Discrete Choice Experiment.
    Chyderiotis S; Sicsic J; Gagneux-Brunon A; Raude J; Barret AS; Bruel S; Gauchet A; Le Duc Banaszuk AS; Michel M; Giraudeau B; Thilly N; Mueller JE;
    Patient; 2024 Sep; 17(5):575-588. PubMed ID: 38693318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatricians' preferences for infant meningococcal vaccination.
    Poulos C; Reed Johnson F; Krishnarajah G; Anonychuk A; Misurski D
    Value Health; 2015 Jan; 18(1):67-77. PubMed ID: 25595236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents.
    Quiambao BP; Jain H; Bavdekar A; Dubey AP; Kolhe D; Bianco V; Van der Wielen M; Miller JM
    Hum Vaccin Immunother; 2016 Aug; 12(8):2162-2168. PubMed ID: 27152501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.